9 results
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... anti-hyperglycemic agents ... anti-hyperglycemic agents ... available to manage Type ... anti-hyperglycemic agents
Summary of Non-Insulin Agents Used to Treat Diabetes

#Diabetes #Pharmacology #Comparison #Table #Medications #Noninsulin #Orals #Agents
of Non-Insulin Agents ... Used to Treat Diabetes ... #Diabetes #Pharmacology ... #Comparison #Table ... Noninsulin #Orals #Agents
Key Characteristics of Old and New Potassium-Binding Agents

- Dr. Edgar V. Lerma https://twitter.com/edgarvlermamd

#Potassium #Binding #KBinders #Kayexelate
Potassium-Binding Agents ... Potassium #Binding #KBinders ... #Kayexelate #Comparison ... #Table #Pharmacology ... HyperKalemia #Nephrology #Agents
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... major adverse CV events ... major adverse CV events ... #comparison #management
Hypersensitivity Types and Their Mechanisms
Type I - lgE - Soluble antigen
 - Allergen-specific lgE antibodies bind
specific allergen binds ... or IgM antibody binds ... I diabetes mellitus ... #Classification ... Diagnosis #Reactions #Table
Table 22 provides the characteristics of various phosphate-binding agents.
#Pharmacology #Nephrology #Phosphate #Phosphorus #Binders #Comparison #Table #Disadvantages
Table 22 provides ... phosphate-binding agents ... Phosphate #Phosphorus #Binders ... #Comparison #Table
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
Potassium-Binding Agents ... calcium for K; also binds ... nonspecifically binds ... #pharmacology #table ... #comparison #binders
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Any adverse events ... , follow ACC algorithm ... What is the type ... Diabetes regimen ... postoperative cardiac events
Causes of Hyperkalemia
l. Pseudohyperkalemia
  A Cellular efflux; thrombocytosis, erythrocytosis, leukocytosis, in vitro hemolysis
  B.
noncardioselective agents ... Diabetes, diabetic ... Pseudohypoaldosteronism type ... pseudohypoaldosteronism type ... High #Potassium #Classification